CLDF Title
Contact Us | Bookmark
About CLDF Centers of Educational Expertise  
Live CME Meetings Telewebs Webcasts Slide Library Abstract Library Conference Highlights
Featured Programs
UEGW 2015     Banner2   IC-Hep
  Liver News - REUTERS   Congress Calendar   Physician Resources  
Grazoprevir-elbasvir effective for hepatitis C in advanced chronic kidney disease
FDA warns of serious liver injury risk with AbbVie hep C drugs
Early HCV fibrosis suggests need for early treatment
Rare gene variant could cause false positives in alcohol-abuse test
View Complete News Library
View all Congresses
  Featured Abstracts          
Towards a more accurate estimate of the prevalence of hepatitis C in the United States
Interferon-free Therapy for Genotype 1 Hepatitis C in Liver Transplant Recipients: Real World Experience from HCV-TARGET
Reduced healthcare utilization following successful hepatitis C virus treatment in HIV-co-infected patients with mild liver disease
Interferon-free regimens containing setrobuvir for patients with genotype 1 chronic hepatitis C: a randomized, multicenter study
Show Me Echo - Hepatitis C: A telemedicine mentoring program for patients with hepatitis C in underserved and rural areas in Missouri as a model in developing countries
Next-Generation Regimens: The Future of Hepatitis C Virus Therapy
Hepatitis delta virus: Making the point from virus isolation up to 2014
Entecavir safety and effectiveness in a national cohort of treatment-naïve chronic hepatitis B patients in the US - the ENUMERATE study
Diagnosing and treating hepatic encephalopathy
Mediation Analysis of Hepatitis B and C in Relation to Hepatocellular Carcinoma Risk
Probiotics are Helpful in Hepatic Encephalopathy: A Meta-Analysis of Randomized Trials
Clinical science workshop: targeting the gut-liver-brain axis
Qualifying and quantifying minimal hepatic encephalopathy
What is new about diet in hepatic encephalopathy
Long-term outcomes of patients with advanced hepatocellular carcinoma who achieved complete remission after sorafenib therapy
Molecular subclasses of hepatocellular carcinoma predict sensitivity to fibroblast growth factor receptor inhibition
General Rules for the Clinical and Pathological Study of Primary Liver Cancer, Nationwide Follow-Up Survey and Clinical Practice Guidelines: The Outstanding Achievements of the Liver Cancer Study Group of Japan
Hepatocellular Carcinoma and Lifestyles
          View All Abstracts  
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Live CME Meetings
Slide Library
Abstract Library
Slide Library
Abstract Library
CLDF Follow Us
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
Centers of
Educational Expertise
Substance Use Disorder
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2015 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.